Urgent

Toxoplasma pneumonia & parasitic pulmonary infections in HIV

Opportunistic infection · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Pulmonary toxoplasmosis is the 2nd most common manifestation of disseminated toxoplasmosis in AIDS (after encephalitis), CD4 typically <100. Presents as fever, non-productive cough and dyspnoea and mimics PCP. Also consider Strongyloides hyperinfection in patients from endemic areas, especially if steroid-exposed.

Red flags

  • Hypoxia / respiratory failure / ARDS
  • Extreme LDH elevation
  • Concurrent CNS toxoplasmosis (headache, focal deficit, seizure)
  • Disseminated disease / sepsis / multi-organ involvement
  • Strongyloides hyperinfection with gram-negative sepsis or haemorrhage

Assessment

Differential diagnosis

  • Pneumocystis jirovecii pneumonia (PCP)
  • Tuberculosis
  • Cryptococcal pneumonia
  • Histoplasmosis
  • Bacterial pneumonia
  • Pulmonary Kaposi sarcoma
  • Strongyloides hyperinfection
  • CMV pneumonitis

Investigations

  • CXR (diffuse bilateral interstitial/alveolar infiltrates; can be nodular/cavitary/lobar/effusion)
  • Serum LDH - markedly/extremely elevated (more than in PCP)
  • Toxoplasma gondii IgG (absence makes it unlikely)
  • CD4 count
  • BAL with Giemsa/methylene-blue stain for tachyzoites (crescent-shaped, 5-7 microns) + PCR
  • Strongyloides serology/stool in endemic areas

Management

  • In advanced HIV (CD4 <100) with fever + respiratory symptoms, consider toxoplasma pneumonitis alongside PCP/TB
  • Check Toxoplasma IgG + serum LDH
  • Obtain BAL for definitive diagnosis (tachyzoites/PCR)
  • Oxygen and supportive care; manage respiratory failure
  • Treat with pyrimethamine + sulfadiazine + leucovorin (same as encephalitis), or TMP-SMX if pyrimethamine unavailable
  • Start/optimise ART (within ~2 weeks of diagnosis in treatment-naive)
  • In endemic/steroid-exposed patients, consider and treat Strongyloides hyperinfection

Drugs & doses

Pyrimethamine + sulfadiazine + leucovorin (folinic acid) - regimen of choice (same as cerebral toxoplasmosis), ~3-6 weeks induction then maintenance/secondary prophylaxis - specific mg doses NOT given in this source (use standard toxoplasmosis dosing; flag)
TMP-SMX (co-trimoxazole) - alternative where pyrimethamine unavailable
Supportive: oxygen, treat respiratory failure
Strongyloides hyperinfection (endemic areas): ivermectin per Strongyloides protocol

Disposition

Admit (hypoxia, diagnostic uncertainty, IV therapy); ID + HIV team; BAL for diagnosis; start ART within ~2 weeks.

Complications & pitfalls

  • Respiratory failure / ARDS
  • Disseminated toxoplasmosis
  • Concurrent toxoplasma encephalitis
  • Strongyloides hyperinfection syndrome
  • IRIS

Exam pearls

  • Markedly elevated LDH + positive Toxoplasma IgG + diffuse infiltrates in CD4 <100 suggests toxoplasma pneumonitis - it mimics PCP; BAL distinguishes
  • A negative Toxoplasma IgG makes pulmonary toxoplasmosis unlikely
  • Screen for and empirically treat Strongyloides before giving steroids in patients from endemic areas

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.